myFibroScan vs MKSAP 19

FibroScan® is the non-invasive gold standard solution for comprehensive management of liver health. FibroScan® is powered by three unique, patented and validated biomarkers, LSM by VCTE™ (Liver Stiffness Measurement) and CAP™ (Controlled Attenuation Parameter) that benefit from a worldwide clinical evidence with over 5300+ peer-reviewed publications and 180+ international guidelines. myFibroScan app is your everyday FibroScan® companion to access Interpretation Guide and FibroScan® based scores in an easy, fast and intuitive way : The Interpretation Guide utilizes data from clinical studies to assist providers in interpreting FibroScan® examination results. Scores enhance FibroScan® liver disease assessment with biological markers. Scores are presented as educational services intended for licensed healthcare professionals. While the scores are about specific medical and healthcare issues, they are not a substitute for/or replacement of personalized medical advice and are not intended to be used as the sole basis for making individualized medical or health-related decisions. • Fast is an aid to identify at risk MASH patients defined as MASH + NAS≥4 + F≥2. Good to excellent performance in cohorts from different clinical settings (MASLD tertiary care unit, screening, bariatric surgery) and geographical origins (USA, Europe, Asia). Several publications advocate the use of Fast. • Agile 3+ is an aid to identify MASLD patients with advanced fibrosis by combining LSM by VCTE™ and routine clinical parameters to reduce the need for liver biopsy. High clinical performances are demonstrated in large external validation cohorts from different geographical origins. • Agile 4 is an aid to early identify MASLD patients with cirrhosis by combining LSM by VCTE™ and routine clinical parameters. It can help the physicians to manage the disease to prevent liver-related complications such as hepatocellular carcinoma. High clinical performances are demonstrated in large external validation cohorts from different geographical origin. MASH Treatment Eligibility Tool to eliminate the Guesswork. This patient management tool embeds treatment recommendations based on the patient’s FibroScan® results and the latest AASLD Guidance.

This app supplements the online version and is included with the MKSAP 19 Digital, MKSAP 19 Complete Green, and MKSAP 19 Complete subscriptions. Simply log in with your ACP or MKSAP 19 username and password. If you need assistance setting up your account, visit ACP Online. Some functionality within the app requires an active internet connection. Your suggestions for future updates and enhanced features are welcome at mksap_editors@acponline.org. The new Medical Knowledge Self-Assessment Program® (MKSAP® 19) provides you with the most current and critical information in the core of internal medicine and its subspecialties so you can stay aware of what you need to know as a practicing physician in internal medicine today. MKSAP 19 consists of well-researched text sections and 1,200 exam-like multiple-choice questions along with hundreds of figures, charts, and tables to enhance your learning experience. MKSAP 19's original, high-quality questions comprise patient-based clinical scenarios based on the latest evidence. Each question will challenge your decision-making, help you discover areas of strength, and target areas for you to update or acquire new knowledge. This app enables subscribers to MKSAP 19 Digital, MKSAP 19 Complete Green, or MKSAP 19 Complete to read all of the text and answer all of the questions offline. When you are connected to the Internet, answers will sync automatically with the online version. The publisher of this app, the American College of Physicians, is the largest medical specialty organization in the United States with members in more than 145 countries worldwide. ACP membership includes 161,000 internal medicine physicians (internists), related subspecialists, and medical students. Internal medicine physicians are specialists who apply scientific knowledge and clinical expertise to the diagnosis, treatment, and compassionate care of adults across the spectrum from health to complex illness.